COST ANALYSIS OF INSULIN DEGLUDEC IN COMPARISON WITH INSULIN GLARGINE U100 IN THE TREATMENT OF TYPE 1 DIABETES MELLITUS IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM

A.D. Piedade; L. Paladini; J.S. Alves; T.d. Gonçalves; F. Griciunas

doi:10.1016/j.jval.2016.03.1285

COST ANALYSIS OF INSULIN DEGLUDEC IN COMPARISON WITH INSULIN GLARGINE U100 IN THE TREATMENT OF TYPE 1 DIABETES MELLITUS IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM

Value in Health ◽

10.1016/j.jval.2016.03.1285 ◽

2016 ◽

Vol 19 (3) ◽

pp. A200

Author(s):

A.D. Piedade ◽

L. Paladini ◽

J.S. Alves ◽

T.d. Gonçalves ◽

F. Griciunas

Keyword(s):

Diabetes Mellitus ◽

Health Care ◽

Type 1 Diabetes ◽

Cost Analysis ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Health Care System ◽

Insulin Degludec ◽

Private Health Care

Download Full-text

COST ANALYSIS OF INSULIN DEGLUDEC IN COMPARISON WITH INSULIN GLARGINE U100 IN THE TREATMENT OF TYPE 1 DIABETES MELLITUS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM

Value in Health ◽

10.1016/j.jval.2016.03.1286 ◽

2016 ◽

Vol 19 (3) ◽

pp. A200-A201

Author(s):

A.D. Piedade ◽

L. Paladini ◽

J.S. Alves ◽

T.d. Gonçalves ◽

F. Griciunas

Keyword(s):

Public Health ◽

Diabetes Mellitus ◽

Health Care ◽

Type 1 Diabetes ◽

Cost Analysis ◽

Insulin Glargine ◽

Insulin Degludec ◽

Public Health Care ◽

Public Health Care System

Download Full-text

Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine in a Basal-Bolus Regimen in Patients with Type 1 Diabetes Mellitus in the United Kingdom

Value in Health ◽

10.1016/j.jval.2013.08.685 ◽

2013 ◽

Vol 16 (7) ◽

pp. A442

Author(s):

B. Chubb ◽

M. Evans ◽

M. Wolden ◽

T. Christensen ◽

J. Gundgaard

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Insulin Degludec ◽

The United Kingdom ◽

Basal Bolus

Download Full-text

Cost-effectiveness of insulin degludec compared with insulin glargine in a basal-bolus regimen in patients with type 1 diabetes mellitus in the UK

Journal of Medical Economics ◽

10.3111/13696998.2014.971160 ◽

2014 ◽

Vol 18 (1) ◽

pp. 56-68 ◽

Cited By ~ 26

Author(s):

M. Evans ◽

M. Wolden ◽

J. Gundgaard ◽

B. Chubb ◽

T. Christensen

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Insulin Degludec ◽

The Uk ◽

Basal Bolus

Download Full-text

Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus

Diabetes Therapy ◽

10.1007/s13300-013-0048-5 ◽

2013 ◽

Vol 4 (2) ◽

pp. 461-472 ◽

Cited By ~ 21

Author(s):

Yoshiki Kusunoki ◽

Tomoyuki Katsuno ◽

Kana Miyakoshi ◽

Takashi Ikawa ◽

Rie Nakae ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Insulin Degludec

Download Full-text

Insulin Glargine Dose and Weight Changes in Underweight, Normal Weight, and Overweight Children Newly Diagnosed with Type 1 Diabetes Mellitus

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1002/phar.2281 ◽

2019 ◽

Vol 39 (7) ◽

pp. 741-748

Author(s):

Bethany Sharpless Chalk ◽

Janet Crane ◽

Gayane Yenokyan ◽

Erika May Pineda ◽

Carlton K.K. Lee

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Normal Weight ◽

Newly Diagnosed ◽

Overweight Children ◽

Weight Changes

Download Full-text

729-P: Efficacy and Safety of Mylan Insulin Glargine Products (MYL-1501D) from Two Manufacturing Processes (Process V and Process VI) in Combination with Insulin Lispro in Subjects with Type 1 Diabetes Mellitus

Diabetes ◽

10.2337/db21-729-p ◽

2021 ◽

Vol 70 (Supplement 1) ◽

pp. 729-P

Author(s):

YARON RAITER ◽

THOMAS BLEVINS ◽

BIN SUN ◽

ANOOP CHULLIKANA ◽

GOPINATH RANGANNA ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Insulin Lispro ◽

Manufacturing Processes ◽

Efficacy And Safety

Download Full-text

A multicentre, UK, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA)

Diabetic Medicine ◽

10.1111/dme.13847 ◽

2018 ◽

Vol 36 (1) ◽

pp. 110-119 ◽

Cited By ~ 3

Author(s):

T. Pang ◽

S. C. Bain ◽

R. Neil A. Black ◽

J. G. Boyle ◽

J. Elliott ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Clinical Practice ◽

Observational Study ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Routine Clinical Practice ◽

Retrospective Observational Study

Download Full-text

Review for "Pharmacokinetic and Pharmacodynamic Bioequivalence of Proposed Biosimilar MYL‐1501D With US and EU Insulin Glargine Formulations in Patients With Type 1 Diabetes Mellitus"

10.1111/dom.13919/v1/review3 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus

Download Full-text

Review for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v1/review1 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Switch Study

Download Full-text

Review for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v1/review3 ◽

2019 ◽

Author(s):

Linsey Gani

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Switch Study

Download Full-text